DE69735897D1 - INDUCING FACTORS OF ENDODERM, HEART AND NEURONAL TISSUE - Google Patents
INDUCING FACTORS OF ENDODERM, HEART AND NEURONAL TISSUEInfo
- Publication number
- DE69735897D1 DE69735897D1 DE69735897T DE69735897T DE69735897D1 DE 69735897 D1 DE69735897 D1 DE 69735897D1 DE 69735897 T DE69735897 T DE 69735897T DE 69735897 T DE69735897 T DE 69735897T DE 69735897 D1 DE69735897 D1 DE 69735897D1
- Authority
- DE
- Germany
- Prior art keywords
- frzb
- cerberus
- designated
- growth factors
- endoderm
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Electrotherapy Devices (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Two novel proteins have been designated "cerberus" and "frzb-1," respectively. Cerberus is expressed as a secreted peptide during embryogenesis of the Xenopus embryo, and is expressed specifically in the head organizer region. This new molecule has endodermal, cardiac, and neural tissue inducing activity, that should prove useful in therapeutic, diagnostic, and clinical applications requiring regeneration, differentiation, or repair of these and other tissues. Frzb-1 is a soluble antagonist of growth factors of the Wnt family that acts by binding to Wnt growth factors in the extracellular space. A third novel protein is designated "PAPC" which promotes the formation of dorsal mesoderm and somites in the embryo.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2015096P | 1996-06-20 | 1996-06-20 | |
US08/878,474 US6133232A (en) | 1996-06-20 | 1997-06-18 | Endoderm, cardiac and neural inducing factors |
PCT/US1997/010942 WO1997048275A1 (en) | 1996-06-20 | 1997-06-19 | Endoderm, cardiac and neural inducing factors |
Publications (1)
Publication Number | Publication Date |
---|---|
DE69735897D1 true DE69735897D1 (en) | 2006-06-22 |
Family
ID=26693096
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69735897T Expired - Fee Related DE69735897D1 (en) | 1996-06-20 | 1997-06-19 | INDUCING FACTORS OF ENDODERM, HEART AND NEURONAL TISSUE |
Country Status (8)
Country | Link |
---|---|
US (1) | US6133232A (en) |
EP (1) | EP0973391B1 (en) |
JP (1) | JP2002514043A (en) |
AT (1) | ATE326138T1 (en) |
AU (1) | AU723210B2 (en) |
CA (1) | CA2258789A1 (en) |
DE (1) | DE69735897D1 (en) |
WO (1) | WO1997048275A1 (en) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7049291B2 (en) * | 1996-10-11 | 2006-05-23 | The United States Of America As Represented By The Department Of Health And Human Services | Isolation and method of using tissue growth-inducing Frzb protein |
US6884871B2 (en) * | 1996-10-11 | 2005-04-26 | The United States Of America As Represented By The Department Of Health And Human Services | Isolation and use of tissue growth-inducing Frzb protein |
AU4981797A (en) * | 1996-10-11 | 1998-05-11 | Government Of The United States Of America, The | Isolation and method of using tissue growth-inducing frzb protein |
AU741708B2 (en) * | 1997-02-11 | 2001-12-06 | Amrad Operations Pty. Limited | A new cytokine family and uses thereof |
WO1998034951A1 (en) * | 1997-02-11 | 1998-08-13 | Amrad Operations Pty. Ltd. | A new cytokine family and uses thereof |
EP0975752A1 (en) * | 1997-04-29 | 2000-02-02 | Regeneron Pharmaceuticals, Inc. | Human cerberus protein |
US6165748A (en) * | 1997-07-11 | 2000-12-26 | Genetics Institute, Inc. | Frazzled nucleotide sequences and expression products |
DE19747418C1 (en) * | 1997-10-27 | 1999-07-15 | Deutsches Krebsforsch | Inhibitor protein of the wnt signaling pathway |
US20030096951A1 (en) * | 1998-08-14 | 2003-05-22 | Kenneth Jacobs | Secreted proteins and polynucleotides encoding them |
US6344541B1 (en) * | 1998-09-25 | 2002-02-05 | Amgen Inc. | DKR polypeptides |
DE10119729A1 (en) | 2001-04-21 | 2002-10-31 | Bayer Cropscience Gmbh | Synergistic herbicidal compositions containing herbicides from the group benzoylcyclohexanediones for use in maize crops |
DE10119727A1 (en) | 2001-04-21 | 2002-10-31 | Bayer Cropscience Gmbh | Synergistic herbicidal compositions containing herbicides from the group of benzoylcyclohexanediones for use in rice crops |
DE10119728A1 (en) | 2001-04-21 | 2002-10-31 | Bayer Cropscience Gmbh | Synergistic herbicidal compositions containing herbicides from the group of benzoylcyclohexanediones for use in rice crops |
US7713526B2 (en) * | 2001-05-01 | 2010-05-11 | The Regents Of The University Of California | Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas |
WO2002088081A2 (en) * | 2001-05-01 | 2002-11-07 | The Regents Of The University Of California | Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas |
US20030044409A1 (en) * | 2001-05-01 | 2003-03-06 | Carson Dennis A. | Immunologic compositions and methods for studying and treating cancers expressing frizzled antigens |
US7193069B2 (en) * | 2002-03-22 | 2007-03-20 | Research Association For Biotechnology | Full-length cDNA |
US20100183695A1 (en) * | 2004-05-27 | 2010-07-22 | John Knopf | Cerberus/coco derivatives and uses thereof |
US9045553B2 (en) | 2004-05-27 | 2015-06-02 | Acceleron Pharma, Inc. | Cerberus/Coco derivatives and uses thereof |
AU2007332819A1 (en) * | 2006-12-08 | 2008-06-19 | Acceleron Pharma Inc. | Uses of cerberus, coco and derivatives thereof |
US10398765B2 (en) | 2014-07-03 | 2019-09-03 | Yale University | Dickkopf2 (Dkk2) inhibition suppresses tumor formation |
CA3003252C (en) | 2015-10-28 | 2024-06-25 | Yale University | Humanized anti-dkk2 antibody and uses thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU676847B2 (en) * | 1992-09-03 | 1997-03-27 | Regeneron Pharmaceuticals, Inc. | Dorsal tissue affecting factor and compositions |
ZA936478B (en) * | 1992-09-03 | 1994-09-30 | Regeneron Pharma | Dorsal tissue affecting factor and compositions |
US5457048A (en) * | 1993-12-03 | 1995-10-10 | La Jolla Cancer Research Foundation | Eph-related tyrosine kinases, nucleotide sequences and methods of use |
-
1997
- 1997-06-18 US US08/878,474 patent/US6133232A/en not_active Expired - Lifetime
- 1997-06-19 EP EP97932262A patent/EP0973391B1/en not_active Expired - Lifetime
- 1997-06-19 AU AU35765/97A patent/AU723210B2/en not_active Ceased
- 1997-06-19 JP JP50346798A patent/JP2002514043A/en active Pending
- 1997-06-19 WO PCT/US1997/010942 patent/WO1997048275A1/en active IP Right Grant
- 1997-06-19 AT AT97932262T patent/ATE326138T1/en not_active IP Right Cessation
- 1997-06-19 CA CA002258789A patent/CA2258789A1/en not_active Abandoned
- 1997-06-19 DE DE69735897T patent/DE69735897D1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US6133232A (en) | 2000-10-17 |
EP0973391A4 (en) | 2003-09-03 |
EP0973391B1 (en) | 2006-05-17 |
EP0973391A1 (en) | 2000-01-26 |
CA2258789A1 (en) | 1997-12-24 |
AU3576597A (en) | 1998-01-07 |
AU723210B2 (en) | 2000-08-17 |
WO1997048275A1 (en) | 1997-12-24 |
ATE326138T1 (en) | 2006-06-15 |
JP2002514043A (en) | 2002-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69735897D1 (en) | INDUCING FACTORS OF ENDODERM, HEART AND NEURONAL TISSUE | |
HUP0105027A2 (en) | Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds and their use | |
Bosch et al. | Axonal signals regulate expression of glia maturation factor-beta in Schwann cells: an immunohistochemical study of injured sciatic nerves and cultured Schwann cells | |
CA2596597A1 (en) | Method for stimulation collagen synthesis and/or kgf expression | |
DE602004026898D1 (en) | COMPOSITIONS FOR THE DIAGNOSIS AND THERAPY OF DISEASES RELATED TO ANOMALICAL EXPRESSION OF FUTRINES (R-SPONDINES) | |
DE69840909D1 (en) | ANALOG OF COCAINE | |
DE69527049T2 (en) | THERAPEUTIC USES OF BACTERICIDES / PERMEABILITY-INCREASING PROTEIN DIMER PRODUCTS | |
WO1996019580A3 (en) | Telomerase protein component | |
AU2010200621A1 (en) | Use of low-dose erythropoietin for stimulation of endothelial progenitor cells, for organ regeneration and for slowing the progression of end-organ damage | |
EA200001247A1 (en) | N-BONDED SULPHONAMIDES OF N-HETEROCYCLIC CARBONIC ACIDS OR ISATERES OF CARBONIC ACIDS | |
WO2001066596A3 (en) | Human fgf-23 gene and gene expression products | |
ATE337339T1 (en) | THERAPEUTIC USE OF SMR1 PROTEIN AND ITS ACTIVE DERIVATIVES | |
DE69221486T2 (en) | BOMBESIN ANALOG | |
CA2193993A1 (en) | New hil-4 mutant proteins used as antagonists or partial agonists of human interleukin 4 | |
DE60138552D1 (en) | PEPTIDES WITH INTEGRIN BINDING MOTIVATION AND TREATMENT METHODS FOR MUSCLE DISEASES | |
MX9307983A (en) | AMINO ACID DERIVATIVES OF HETERO CYCLES AS PROTEIN QUINASE C. INHIBITORS | |
ATE294236T1 (en) | PROMOTER OF THE TIE RECEPTOR PROTEIN KINASE | |
NZ332829A (en) | Use of a polypeptide corresponding to a serine threonine kinase receptor, ALK-7 for neurological diseases | |
DE69501359T2 (en) | Use of phosphate diesters for the treatment of diseases of the retina | |
EP0948536A4 (en) | A g protein-coupled receptor with an enlarged extracellular domain | |
ES2135398T3 (en) | COMPOUND AND COMPOSITIONS OF INHIBITION OF BONE RESORPTION. | |
KR100488038B1 (en) | New bpc peptide salts with organo-protective activity the process for their preparation and their use in therapy | |
EP1059931B1 (en) | Utilization of cd137 in order to promote the proliferation of peripheral monocytes | |
DE69102069D1 (en) | 5-AMINOSALICYLIC ACID DERIVATIVES FOR THE TREATMENT OF CHRONICALLY INFLAMMABLE BELLY DISEASES. | |
KR960000248A (en) | Bone Metabolism Disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8339 | Ceased/non-payment of the annual fee |